Martin Marietta Announces Fourth-Quarter And Full-Year 2022 ...| MENAFN.COM

Wednesday, 01 February 2023 01:45 GMT

Martin Marietta Announces Fourth-Quarter And Full-Year 2022 Earnings Conference Call

(MENAFN- GlobeNewsWire - Nasdaq)

RALEIGH, N.C., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Martin Marietta Materials, Inc. (NYSE:MLM) (“Martin Marietta” or the“Company”) will host its fourth-quarter and full-year 2022 earnings conference call on Wednesday, February 15, 2023 at 10:00 a.m. Eastern Time. The Company will release results for the quarter and year ended December 31, 2022, that morning before the market opens.

A live, listen-only webcast and supplemental information will be accessible on the Investors section of the Company's website at . The conference call may also be accessed by registering here: . Please register at least 15 minutes in advance to ensure a timely connection to the call. An on-demand replay will be available on the Company's website approximately two hours following the conclusion of the live broadcast and will be available for one year.

Martin Marietta, a member of the S&P 500 Index, is an American-based company and a leading supplier of building materials, including aggregates, cement, ready mixed concrete and asphalt. Through a network of operations spanning 28 states, Canada and The Bahamas, dedicated Martin Marietta teams supply the resources necessary for building the solid foundations on which our communities thrive. Martin Marietta's Magnesia Specialties business provides a full range of magnesium oxide, magnesium hydroxide and dolomitic lime products. For more information, visit or .

Investor Contact:
Jennifer Park
Vice President, Investor Relations
(919) 510-4736



Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.